Roxanna Korologou-Linden

Postdoc in ageing epidemiology
Imperial College London

[Oriol Perera-Cruz @operera_cruz]

Last week I had the honour and privilege to participate in the amazing #BiomarkersCourse at @ucl. What an intense, insightful and unique experience! I was even luckier to work with this talented researchers in what ended up being the best project! @BarcelonaBeta @goteborgsuni

[Roxanna Korologou-Linden @roxanna_ste]

@marina_vab @BristolUni @ExeterMed @BrisCancerEpi Congratulations!!

[Roxanna Korologou-Linden @roxanna_ste]

@emmylooroll @MarioniGroup @atsommerlad ...and obviously it goes without saying I am immensely grateful to my fantastic supervisors @emmylooroll ,@nm_davies ,@laurahowe_epi and Yoav Ben-Shlomo for being very supportive throughout the 4 years of my PhD. I cannot think of a better team of supervisors!

[Roxanna Korologou-Linden @roxanna_ste]

@emmylooroll @MarioniGroup @atsommerlad Thanks again @atsommerlad and @MarioniGroup. It was great to discuss my research with experts in the field!

[Roxanna Korologou-Linden @roxanna_ste]

@PWGTennant @emmylooroll @MarioniGroup @atsommerlad Thank you!! :)

[Roxanna Korologou-Linden @roxanna_ste]

@stergiakouli @emmylooroll @MarioniGroup @atsommerlad Thank you Evie :)

[Roxanna Korologou-Linden @roxanna_ste]

@SheaJAndrews @emmylooroll @MarioniGroup @atsommerlad Thanks Shea! The mock viva was very helpful :)

[Roxanna Korologou-Linden @roxanna_ste]

@DanielHermes1 @NatureComms No it was cross-sectional. UK biobank was divided into three equal sub-samples.

[Roxanna Korologou-Linden @roxanna_ste]

Our paper 'The causes and consequences of Alzheimer's disease: phenome-wide evidence from Mendelian randomization' is now available from @NatureComms.

[Roxanna Korologou-Linden @roxanna_ste]

Link to the article ⤵️ https://t.co/HOfLx2Lpdm

[Roxanna Korologou-Linden @roxanna_ste]

@louise_millard, @dylan_wi11iams, Yoav Ben-Shlomo and Katarina Kolaric!